Handbook of Experimental Pharmacology - Part 5 ppsx
Handbook of Experimental Pharmacology - Part 5 ppsx
... potassium current IKs by (R )-2 -( 2,4-trifluoromethyl)-N-[2-oxo- 5-
phenyl- 1-( 2,2,2-trifluoroethyl )-2 , 3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]acetamide.
J Med Chem 40:38 65 3868
Sesti F, Tai KK, Goldstein ... determinants of
dofetilide block of HERG K+ channels. Circ Res 82:386–3 95
Ficker E, Jaro limek W, Brown AM (2001) Molecular determinants of inactivation and
dofetil...
Handbook of sexual dysfunction - part 5 ppsx
... clitoris. Journal of Anatomy 1998; 159 :1892–1897.
25. Grafenberg E. The role of the urethra in female orgasm. International Journal of
Sexology 1 950 ; 3:1 45 148.
26. Levin RJ. The mechanisms of human female ... result of absence of sexual stimu-
lation or of lack of knowledge about, bad technique of, a lack of attention for,
or negative emotions to sexual stimuli—explai...
Handbook of Experimental Pharmacology - Part 1 pps
... Tables
ISSN 017 1-2 004
ISBN-10 3 -5 4 0-2 496 7-2 Springer Berlin Heidelberg New York
ISBN-13 97 8-3 -5 4 0-2 496 7-2 Springer Berlin Heidelberg New York
Library of Congress Control Number: 20 059 254 72
This work ... 201
Shiroshita-Takeshita, A. 2 35
Sipido, K.R. 159
Tsuji, Y. 2 35
Varro, A. 159
Viswanathan, P.C. 331
Wehrens, X.H.T. 123
Zicha, S. 2 35
HistoryofArrhythmia...
Handbook of Experimental Pharmacology - Part 1 docx
... New method for terminating cardiac arrhyth-
mias. Use of synchronized capacitor discharge. JAMA 182 :54 8 55 5
Lüderitz B (19 95) History of the disorders of cardiac rhythm, second edn. Futura Publishing
Company, ... MolecularDescription 54
3.3 Regional Distribution of HCN Isoforms and MiRP1 55
3.4 Approaches for Region-Specific Modification of I
f
56
4RoleofI
f
in Generating C...
Handbook of Experimental Pharmacology - Part 3 pdf
... DM (1999) Inhibition of P-glyco-
protein-mediated drug transport: a unifying mechanism to explain the interaction be-
tween digoxin and quinidine. Circulation 99 :55 2 55 7
Hoffmeyer S, B urkO, von ... (2004) Voltage-dependent gating of hyperpolarization-
activated, cyclic nucleotide-gated pacemaker channels: molecular coupling between the
S4-S5 and C-linkers. J Biol Chem 279:13 859 –138...
Handbook of Experimental Pharmacology - Part 4 doc
... actions of antiarrh ythmic drugs. Am J Cardiol
59 :E10–E18
Rosen MR, Hoffman BF, Wit AL (19 75) Electrophysiology and pharmacology of cardiac-
arrhythmias. 5. Cardiac antiarrhythmic effects of lidocaine. ... that form part of the contact points with inner mouth
blockers are present (Fig. 2a).
The lack of the P-X-P sequence in the S6 domain of KCNH2 creates a large
volume of...
Handbook of Experimental Pharmacology - Part 6 pdf
... Na
(+)
-Ca(2+) exchangers by 7-
chloro-3 , 5- dihydro -5 - phenyl-1H-4,1-benzothiazepine-2-one (CGP-37 157 ). J Pharmacol
Exp Ther 306:1 050 –1 057
Paulus WJ, Goethals MA, Sys SU (1992) Failure of myocardial inactivation: ... inhibition of Na
+
/Ca
2+
exchange by SN-6 [ 2-[ 4-
(4-nitrobenzyloxy)benzyl]thiazolidine-4-carboxylic acid ethyl ester], a novel benzy-
loxyphenyl derivati...
Handbook of Experimental Pharmacology - Part 7 pot
... (1990) KN-62,
1-[ N,O-bis ( 5- isoquinolinesulfonyl)-N-methyl-L-tyrosyl ]-4 -phenylpiperazine, a specific
inhibitor of Ca
2+
/calmodulin-dependent protein kinase II. J Biol Chem 2 65: 43 15 4320
Toyofuku ... Arrhythmia Treated by
β-Blockers 250
5. 1 Prophylactic U se of β-Blockers in Myocardial Infarction . 251
5. 2 Prophylactic U se of β-BlockersinCongestiveHeartFailure 251
5. 3...
Handbook of Experimental Pharmacology - Part 8 pdf
... amiodaro ne, which has
non-competitive
β-antagonist properties, does not replace β-blockers, and it
underlines the significance of the use of
β-blockers.
5. 2
Prophylactic Use of
β-Blockers in Congestive ... of
β-blockers in CHF is the prevention of sud-
den arrhythmic death (Cleophas and Zwinderman 2001). Such benefits may
be due to the prevention of proarrhythmic effects of
β-a...
Handbook of Experimental Pharmacology - Part 9 doc
... (2002) Increased risk of arrh ythmic events in long-QT
syndrome wi th mutations in the pore region of the human ether-a-go-go-related gene
potassium channel. Circulation 1 05: 794–799
Motoike HK, ... 171:287–304
© Springer-Verlag Berlin Heidelberg 2006
Mutation-Specific Pharmacology of the Long QT Syndrome
R.S. Kass
1
(✉)·A.J.Moss
2
1
Department of Pharmacology, Columbia Uni versit...